| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2007 | 2019 | ||||||||
|
solute carrier family 6 member 2 | 0.490 | 0.846 | 8.2E-02 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 1999 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2009 | 2020 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2003 | 2020 | ||||||||
|
clock circadian regulator | 0.463 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2000 | 2019 | ||||||||
|
neurotrophic receptor tyrosine kinase 2 | 0.479 | 0.808 | 1.00 |
|
disease | 0.380 | None | 1.000 | 5 | 0 | 2005 | 2018 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
disease | 0.380 | None | 1.000 | 5 | 0 | 2004 | 2020 | ||||||||
|
G protein subunit beta 3 | 0.518 | 0.808 | 3.3E-11 |
|
disease | 0.380 | None | 0.600 | 5 | 0 | 2004 | 2017 | ||||||||
|
5-hydroxytryptamine receptor 1B | 0.551 | 0.769 | 0.19 |
|
disease | 0.360 | None | 0.800 | 5 | 0 | 2003 | 2018 | ||||||||
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
disease | 0.360 | None | 1.000 | 5 | 0 | 1993 | 2017 | ||||||||
|
dystrobrevin binding protein 1 | 0.588 | 0.615 | 6.8E-06 |
|
disease | 0.360 | None | 1.000 | 5 | 0 | 2004 | 2015 | ||||||||
|
cytochrome P450 family 2 subfamily C member 19 | 0.467 | 0.846 | 6.5E-20 |
|
disease | 0.360 | None | 1.000 | 5 | 0 | 1996 | 2020 | ||||||||
|
dopamine receptor D4 | 0.517 | 0.577 | 9.3E-09 |
|
disease | 0.340 | None | 0.800 | 5 | 0 | 1999 | 2016 | ||||||||
|
D-amino acid oxidase activator | 0.678 | 0.346 | 1.4E-04 |
|
disease | 0.340 | None | 0.800 | 5 | 0 | 2011 | 2017 | ||||||||
|
tryptophan 2,3-dioxygenase | 0.599 | 0.654 | 2.0E-10 |
|
disease | 0.330 | None | 0.800 | 5 | 0 | 2006 | 2018 | ||||||||
|
DEAF1 transcription factor | 0.575 | 0.615 | 3.4E-04 |
|
disease | 0.310 | None | 1.000 | 5 | 0 | 2004 | 2012 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.390 | None | 1.000 | 4 | 0 | 2007 | 2020 | ||||||||
|
glial cell derived neurotrophic factor | 0.434 | 0.885 | 0.20 |
|
disease | 0.370 | None | 1.000 | 4 | 0 | 2008 | 2019 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.350 | None | 1.000 | 4 | 0 | 2008 | 2018 | ||||||||
|
PDZ and LIM domain 5 | 0.525 | 0.808 | 1.7E-03 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2005 | 2017 | ||||||||
|
discs large MAGUK scaffold protein 4 | 0.595 | 0.654 | 1.00 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2004 | 2017 | ||||||||
|
S100 calcium binding protein B | 0.383 | 0.923 | 4.4E-02 |
|
disease | 0.340 | None | 0.750 | 4 | 0 | 2008 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily C member 9 | 0.506 | 0.885 | 1.3E-10 |
|
disease | 0.330 | None | 0.750 | 4 | 0 | 2003 | 2013 | ||||||||
|
tyrosine hydroxylase | 0.462 | 0.885 | 1.7E-06 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 1991 | 2019 | ||||||||
|
prodynorphin | 0.535 | 0.577 | 1.7E-04 |
|
disease | 0.320 | None | 1.000 | 4 | 0 | 2001 | 2013 |